SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-12-002603
Filing Date
2012-11-19
Accepted
2012-11-19 07:32:54
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 biostarpharma10q093012.htm 10-Q 1469439
2 ex31-1.htm EX-31.1 15361
3 ex31-2.htm EX-31.2 15413
4 ex32-1.htm EX-32.1 5991
5 ex32-2.htm EX-32.2 5850
  Complete submission text file 0001185185-12-002603.txt   6577776

Data Files

Seq Description Document Type Size
6 bspm-20120930.xml EX-101.INS 1121374
7 bspm-20120930.xsd EX-101.SCH 41808
8 bspm-20120930_cal.xml EX-101.CAL 39550
9 bspm-20120930_def.xml EX-101.DEF 213972
10 bspm-20120930_lab.xml EX-101.LAB 280276
11 bspm-20120930_pre.xml EX-101.PRE 217111
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34708 | Film No.: 121213139
SIC: 2834 Pharmaceutical Preparations